JD Health International, Inc.

As of June 30, 2026, JD HEALTH INTL INC. carries a market capitalization of 18.77B, placing it among publicly traded companies globally. Its enterprise value stands at 11.64B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

JD HEALTH INTL INC.'s next confirmed earnings release is scheduled for March 29, 2027.

As of June 30, 2026, JD HEALTH INTL INC. has 3.19B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, JD HEALTH INTL INC. maintains a current ratio of 2.69, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 16, 2026, JD HEALTH INTL INC.'s stock has declined approximately 42.84% over the past 52 weeks.

As of June 30, 2026, JD HEALTH INTL INC. holds 7.26B in cash and equivalents against 128.95M in total debt, resulting in a net debt position of -3.01B. Total book value stands at 9.06B, with working capital of 5.37B providing operational flexibility.